Pharmaceutical Branding & Clinical Trial Design
6 Egg Design is a Dublin based pharmaceutical branding studio working with pharma companies, biotech organisations and clinical research teams across Ireland, the UK and Europe.We specialise in clinical trial branding, patient facing materials, regulatory aware design systems and pharmaceutical event design.
Our work is built for complex, multimarket environments where clarity, consistency and compliance are not optional extras.We have worked with organisations including Biodexa Pharmaceuticals, Novo Nordisk and AbbVie. We regularly support confidential and unannounced clinical programmes under NDA.
Pharmaceutical Branding Services
We provide branding and design support for pharmaceutical companies. We have a particular focus on clinical trial environments where clarity, consistency, and compliance are essential.
Clinical trial branding requires absolute clarity, consistency, and an understanding of regulated pharmaceutical environments. We create clinical trial branding and identity systems that support study recognition, investigator engagement, and internal alignment, while remaining flexible across trial phases, regions, and communication channels. Our work ensures each clinical study has a clear, professional visual identity that can be confidently deployed across digital, print, and event-based materials.
Clinical Trial Branding & Identity Systems
We provide specialist pharmaceutical event and conference branding for investigator meetings, scientific congresses, and internal corporate events. From large-scale environmental graphics to supporting digital and printed assets, our event branding solutions ensure consistent visual communication across venues and regions. This experience allows pharmaceutical organisations to present a cohesive brand presence at both local and international events.
Pharmaceutical Event & Conference Branding
We design high-quality printed materials for pharmaceutical companies, including brochures, flyers, information packs, and study documentation used in clinical and corporate settings. Our approach focuses on clear visual hierarchy, accurate information presentation, and brand consistency, ensuring printed assets support comprehension while aligning with regulatory and internal review processes. These materials are designed to integrate seamlessly with wider clinical trial branding and corporate identity systems.
clinical Information Pack design
Pharmaceutical design demands an awareness of regulatory constraints, review processes, and risk mitigation. We deliver regulatory-aware design solutions that prioritise clarity, consistency, and controlled messaging, helping pharmaceutical teams maintain visual standards across multiple markets. Our experience working within compliance-driven environments allows us to create design systems that reduce risk while supporting efficient global rollout.
Regulatory-Aware & Compliant Design
We design patient facing materials for clinical trials including information leaflets, form layouts, recruitment brochures and study welcome packs. Our approach centres on making complex medical information accessible and trustworthy to the patients who need to understand it. We work within regulatory and ethical review requirements and design materials that support informed consent, trial recruitment and patient retention throughout the study.
Patient Information & Recruitment Materials
Have a look at our Logo Design & Brand Identity services.
Why Pharma Companies Choose 6 Egg Design
Experience in clinical trial environments
Proven work with multinational pharma organisations
Clear understanding of regulatory constraints
Design systems built for global consistency
Dublin-based, working across Ireland and Europe
Have a corporate event coming up?
Click here to see how we can help.
Featured pharmaceutical Experience
We worked with Biodexa Pharmaceuticals to develop the complete brand identity for the Serenta clinical study, a trial investigating treatment for Familial Adenomatous Polyposis. The brief called for a study identity that could support patient recruitment and engagement while remaining appropriate for a regulated clinical environment.We developed a full identity system including logo suite, visual guidelines and branded assets for use across digital, printed and event based materials. The system was designed to work consistently across the full lifecycle of the trial, from initial patient outreach through to investigator communications and study documentation.
See the full Serenta Brand Project here.
Clinical Trial Branding
Client
Biodexa Pharmaceuticals
Year
20/09/2025
Our Process
Our pharmaceutical branding process is designed to support clarity, compliance, and consistency across complex clinical and corporate environments. Each stage is structured to align with internal review processes while maintaining creativity.
Discovery & regulatory context:
We begin by understanding the clinical, regulatory, and organisational environment surrounding the project, ensuring design decisions align with internal standards and compliance requirements.
Stakeholder alignment
We work closely with internal teams and external partners to establish clear objectives, approval pathways, and brand requirements before creative development begins.
Design system development
Visual identity systems are developed to support scalability across materials, markets, and project phases, ensuring long-term consistency.
Review & refinement
Designs are refined through structured review stages, allowing for accurate feedback and efficient iteration within regulated workflows.
Rollout & support
Final assets are prepared for deployment across digital, print, and event environments, with ongoing support provided as projects evolve.
Frequently Asked Questions
-
Yes. A core part of our work focuses on clinical trial branding, including the development of study identities, visual systems, and supporting materials used across digital, print, and event environments. We understand the need for clarity, consistency, and structured design approaches within regulated clinical settings.
-
Yes. We regularly work under non-disclosure agreements (NDAs) and are experienced in supporting confidential and unannounced pharmaceutical and clinical trial projects.
-
Yes. We have experience working with multinational pharmaceutical companies and supporting branding projects that span Ireland, the UK, and Europe. Our design systems are built to scale across regions and teams while maintaining visual consistency.
-
We support a wide range of pharmaceutical branding projects, including clinical trial branding, printed materials such as brochures and information packs, and pharmaceutical event and conference branding. Our work is tailored to meet internal review processes and compliance requirements.
-
Regulatory-aware design refers to a design approach that is built around the constraints and requirements of regulated pharmaceutical environments. In practice this means understanding that materials may go through medical, legal, and regulatory review before they can be used — and designing with that in mind from the start. It involves clear visual hierarchy, controlled messaging, careful use of claims and language, and the creation of design systems that can be reviewed, amended, and updated without losing consistency. For pharmaceutical teams, working with a studio that understands this from the outset significantly reduces the number of review cycles needed and the risk of materials needing to be redesigned late in the process.
-
Yes. Developing brand guidelines for clinical studies is a core part of what we do. Once a trial identity has been established, we produce a set of guidelines that covers logo usage, colour palette, typography, layout principles, and guidance on how the identity should be applied across the different materials and markets involved in the study. These guidelines are practical documents designed to be used by internal teams, site staff, and any other partners working on the study — not just the design studio. They are built to be clear enough that anyone picking them up can apply the brand correctly without needing to come back to us for every decision.
-
It depends on the scope, but as a general guide, developing a full clinical trial brand identity — including logo, visual system, and brand guidelines — typically takes four to six weeks from a confirmed brief. If the project also includes a suite of materials such as patient recruitment assets, site initiation packs, or event collateral, the timeline extends accordingly. For projects with tighter timelines due to study start-up schedules, we are used to working within those constraints and will always be upfront about what is realistic. Getting in touch early in the planning process gives us the best chance of delivering everything you need ahead of your key milestones.